Tamiflu works in confirmed cases: study
Tamiflu reduces the length of flu symptoms, complications and hospital admissions but it is unclear whether the benefits outweigh the harms, say researchers.
Results of a meta-analysis published in The Lancet show treating adults with laboratory-confirmed influenza reduces the duration of symptoms by 21% compared with placebo (from 123 hours to 98 hours). No benefit was noted in those without a flu infection.
Oseltamivir also reduces the risk of lower respiratory